Target-controlled infusion of remifentanil or fentanyl during extra-corporeal shock-wave lithotripsy

European Journal of Anaesthesiology

Volumn 22, Issue 1, 2005, Pages 56-61

  Cortínez, Luis I ^a   Munoz H R ^a   De La Fuente, R ^a   Acuna D ^a   Dagnino, J A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Pharmacology, fentanyl, remifentanil, target controlled infusion, respiratory depression; Surgical procedures, extra corporeal shock wave lithotripsy

Indexed keywords

FENTANYL; REMIFENTANIL; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; ANALGESIA; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; EXTRACORPOREAL LITHOTRIPSY; FEMALE; HUMAN; HYPOXEMIA; INFUSION PUMP; MALE; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SHOCK WAVE; VOMITING; ADOLESCENT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONSCIOUS SEDATION; DRUG DELIVERY SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LITHOTRIPSY; LUNG FUNCTION TEST; MIDDLE AGED; PAIN;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANOXEMIA; CONSCIOUS SEDATION; DRUG DELIVERY SYSTEMS; FEMALE; FENTANYL; HUMANS; INFUSIONS, INTRAVENOUS; LITHOTRIPSY; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PIPERIDINES; RESPIRATORY FUNCTION TESTS; VOMITING;

EID: 20644447826     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021505000128     Document Type: Article

References (22)

1. Gravenstein D. Extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Anesthesiol Clin North Am 2000; 18: 953-971.
2. Coloma M, Chiu JW, White PF, et al. Fast-tracking after immersion lithotripsy: general anesthesia versus monitored anesthesia care. Anesth Analg 2000; 91: 92-96.
3. Bromage PR, Bonsu AK, el-Faqih SR, Husain I. Influence of Dornier HM3 system on respiration during extracorporeal shock-wave lithotripsy. Anesth Analg 1989; 68: 363-367.
4. Sa Rego MM, Inagaki Y, White PF. Remifentanil administration during monitored anesthesia care: are intermittent boluses an effective alternative to a continuous infusion? Anesth Analg 1999; 88: 518-522.
5. Gesztesi Z, Rego MM, White PF. The comparative effectiveness of fentanyl and its newer analogs during extracorporeal shock wave lithotripsy under monitored anesthesia care. Anesth Analg 2000; 90: 567-570.
6. Beloeil H, Corsia G, Coriat P, Riou B. Remifentanil compared with sufentanil during extra-corporeal shock wave lithotripsy with spontaneous ventilation: a double-blind, randomized study. Br J Anaesth 2002; 89: 567-570.
7. Shafer SL, Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm 1992; 20: 147-169.
8. 2 through nasal cannulae. Anesthesiology 1987; 67: 606.
9. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24-33.
10. McClain DA, Hug Jr CC. Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980; 28: 106-114.
11. Dixon W, Massey FJ. Introduction to Statistical Analysis. New York, USA: McGraw-Hill, 1969.
12. Maitre PO, Vozeh S, Heykants J, et al. Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 1987; 66: 3-12.
13. Ausems ME, Vuyk J, Hug Jr CC, Stanski DR. Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology 1988; 68: 851-861.
14. Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiology 2001; 95: 1362-1370.
15. Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990; 73: 1091-1102.
16. Mertens MJ, Engbers FH, Burm AG, Vuyk J. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth 2003; 90: 132-141.
17. McEwan AI, Smith C, Dyar O, et al. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 1993; 78: 864-869.
18. Lang E, Kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996; 85: 721-728.
19. Puchner W, Egger P, Puhringer F, et al. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 2002; 46: 350-354.
20. Chen SW, Maguire PA, Davies MF, et al. Evidence for mulopioid receptor involvement in fentanyl-mediated respiratory depression. Eur J Pharmacol 1996; 312: 241-244.
21. Joshi GP, Warner DS, Twersky RS, Fleisher LA. A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study. J Clin Anesth 2002; 14: 494-499.
22. Joo HS, Perks WJ, Kataoka MT, et al. A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy. Anesth Analg 2001; 93: 1227-1232.